1. Home
  2. CVAC vs HIFS Comparison

CVAC vs HIFS Comparison

Compare CVAC & HIFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVAC
  • HIFS
  • Stock Information
  • Founded
  • CVAC 2000
  • HIFS 1834
  • Country
  • CVAC Germany
  • HIFS United States
  • Employees
  • CVAC N/A
  • HIFS N/A
  • Industry
  • CVAC Biotechnology: Pharmaceutical Preparations
  • HIFS Major Banks
  • Sector
  • CVAC Health Care
  • HIFS Finance
  • Exchange
  • CVAC Nasdaq
  • HIFS Nasdaq
  • Market Cap
  • CVAC 764.4M
  • HIFS 581.6M
  • IPO Year
  • CVAC 2020
  • HIFS N/A
  • Fundamental
  • Price
  • CVAC $5.40
  • HIFS $245.76
  • Analyst Decision
  • CVAC Hold
  • HIFS
  • Analyst Count
  • CVAC 3
  • HIFS 0
  • Target Price
  • CVAC $6.83
  • HIFS N/A
  • AVG Volume (30 Days)
  • CVAC 2.1M
  • HIFS 94.8K
  • Earning Date
  • CVAC 08-14-2025
  • HIFS 07-11-2025
  • Dividend Yield
  • CVAC N/A
  • HIFS 1.02%
  • EPS Growth
  • CVAC N/A
  • HIFS 14.93
  • EPS
  • CVAC 0.87
  • HIFS 12.96
  • Revenue
  • CVAC $566,039,775.00
  • HIFS $67,590,000.00
  • Revenue This Year
  • CVAC N/A
  • HIFS N/A
  • Revenue Next Year
  • CVAC $24.04
  • HIFS N/A
  • P/E Ratio
  • CVAC $6.24
  • HIFS $18.96
  • Revenue Growth
  • CVAC 787.60
  • HIFS 12.43
  • 52 Week Low
  • CVAC $2.37
  • HIFS $174.39
  • 52 Week High
  • CVAC $5.72
  • HIFS $300.00
  • Technical
  • Relative Strength Index (RSI)
  • CVAC 65.68
  • HIFS 57.80
  • Support Level
  • CVAC $5.30
  • HIFS $230.07
  • Resistance Level
  • CVAC $5.58
  • HIFS $236.74
  • Average True Range (ATR)
  • CVAC 0.15
  • HIFS 5.90
  • MACD
  • CVAC 0.00
  • HIFS 2.36
  • Stochastic Oscillator
  • CVAC 80.66
  • HIFS 99.56

About CVAC CureVac N.V.

CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.

About HIFS Hingham Institution for Savings

Hingham Institution for Savings is a savings bank based in Hingham, Massachusetts, and is involved in the business of residential and commercial real estate mortgage lending and also financial and banking services. The bank's financial services include personal checking accounts, personal mortgages, home equity lines of credit, money market accounts, savings accounts, certificates of deposit, and business checking accounts. Its lending portfolio mainly encompasses commercial real estate, residential owner-occupied real estate, and loans for the construction of residential real estate.

Share on Social Networks: